|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Net revenues (including sales to related parties of $2,449,560, $286,875 and nil for the years ended December 31, 2020, 2021 and 2022, respectively) | ||||
| Net revenues | ||||
| Sale of software products | ||||
| Sale of hardware products | ||||
| Technology development service | ||||
| M&S service | ||||
| Sale of cloud platform products | ||||
| Total net revenues | ||||
| Cost of revenues | ||||
| Sale of software products | ||||
| Sale of hardware products | ||||
| Technology development service | ||||
| M&S service | ||||
| Sale of cloud platform products | ||||
| Total cost of revenues | ||||
| Gross profit | ||||
| Operating expenses: | ||||
| Selling expenses | ||||
| General and administrative expenses | ||||
| Research and development expenses | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Other income/(expenses): | ||||
| Investment (loss)/income | ||||
| Interest expenses, net | ||||
| Foreign currency exchange (loss)/gain | ||||
| Gain (Loss) from disposal of property, plant and equipment | ||||
| Impairment loss on an unconsolidated entity | ||||
| Other income, net | ||||
| Total other expenses | ||||
| Loss before income tax expense | ||||
| Income tax expense | ||||
| Net loss | ||||
| Net loss attributable to non-controlling interests | ||||
| Net loss attributable to XIAO-I CORPORATION shareholders | ||||
| Other comprehensive income | ||||
| Foreign currency translation change, net of nil income taxes | ||||
| Total other comprehensive income | ||||
| Total comprehensive loss | ||||
| Total comprehensive income/(loss) attributable to non-controlling interests | ||||
| Total comprehensive loss attributable to XIAO-I CORPORATION shareholders | ||||
| Loss per ordinary share attributable to XIAO-I CORPORATION shareholders | ||||
| Basic (in Dollars per share) | ||||
| Diluted (in Dollars per share) | ||||
| Weighted average number of ordinary shares outstanding | ||||
| Basic (in Shares) | ||||
| Diluted (in Shares) | ||||
| Share based compensation | ||||
| Selling expenses | ||||
| General and administrative expenses | ||||
| Research and development expenses | ||||
| Total share based compensation | ||||
Loading...